mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
0.13 |
0.008 |
mRNA |
shikonin |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.008 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.009 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.009 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.009 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.01 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.01 |